Nexira introduces products for appetite control and microbiome modulation

Published: 16-Aug-2023

Nexira is set to introduce its new Carolean product, a solution for weight management. It combines the company’s recently acquired carob ingredients with its legacy nopal cactus nutraceuticals

Acacia specialist Nexira has introduced two new products for appetite control and microbiome modulation, set to be introduced to the North American market at the upcoming Supply Side West. 

Consumers consistently rate weight loss as top health concern, with 40% of the consumers who globally want to lose weight in 2020. However, the approach and the needs have changed: consumers are now willing to consider weight management through a holistic way, as part of a healthy diet and lifestyle. 

Appetite control 

In the quest of getting healthier and fitter, it is sometimes useful to get extra support to boost motivation. Carolean is a proprietary patent-pending complex specifically designed for appetite control. 

With over 20 years of experience and unrivalled expertise on sourcing and processing, Nexira has established a leading position with its star ingredient: Cactus on the weight management market. 

Our in vitro study has been designed to mimic the ingestion in terms of temperature and pH. Carolean has shown a superior kinetic compared to market standards

The recent acquisition of a Swiss footprint - expert in Carob processing - allows Nexira to add valuable resource to address satiety consumer’s objectives. 

Carolean complex is the fruit of combined R&D efforts to design an innovative solution that provides both effectiveness and convenience for appetite control. Carolean is a patent-pending complex, combining carob and nopal. Synergistic efficacy has been demonstrated to show the superiority of Carolean complex vs single ingredients to reduce appetite and limit cravings. Simply put, each ingredient has a limited capacity of viscosity but when combined, the viscosity becomes exponential contributing to extremely positive results when ingested.

A spokesperson for Nexira said: "Our in vitro study has been designed to mimic the ingestion in terms of temperature and pH. Carolean has shown a superior kinetic compared to market standards. Fifteen minutes after ingestion, already 70% of the viscosity is reached which optimises the satiety effect more rapidly."

They continued: "After 75 to 80 minutes, Carolean complex is released allowing optimised digestion and no digestive discomfort. The recommended use level is 1g daily, which allows the EU pending claim for caron." 

You may also like